Informing Patients About Drugs

Summary Report on Alternative Designs for Prescription Drug Leaflets

by David E. Kanouse, Sandra H. Berry, Barbara Hayes-Roth, William H. Rogers, John D. Winkler

Download

Download eBook for Free

FormatFile SizeNotes
PDF file 2 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

Purchase

Purchase Print Copy

 FormatList Price Price
Add to Cart Paperback45 pages $23.00 $18.40 20% Web Discount

The research reported is the most thorough investigation to date on the effects of patient package inserts (PPIs). Users of each of three prescription drugs (conjugated estrogens, erythromycin, and flurazepam hydrochloride) received one of several different prototype PPIs with their prescriptions and were subsequently interviewed by telephone. For two of the three drugs studied, the design provided a control group that received no PPI. The principal findings include: (1) PPIs are likely to be widely read; (2) patients learn from written drug information and find it helpful; (3) PPIs seem to have little effect on how patients use a drug; (4) warning patients about potential drug side effects does not, by itself, cause patients to experience these effects through suggestion; (5) there is little advantage to be gained by highlighting information about a drug's risks; and (6) the simplicity with which a PPI is written has surprisingly little effect.

This report is part of the RAND Corporation Report series. The report was a product of the RAND Corporation from 1948 to 1993 that represented the principal publication documenting and transmitting RAND's major research findings and final research.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.